HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William R Freeman Selected Research

Epiretinal Membrane (Epiretinal Membranes)

7/2019COMPARISON OF RETINAL PATHOLOGY VISUALIZATION IN MULTISPECTRAL SCANNING LASER IMAGING.
2/2018VISUALIZATION OF MACULAR PUCKER BY MULTICOLOR SCANNING LASER IMAGING.
11/2017CHARACTERISTICS OF EPIRETINAL MEMBRANE REMNANT EDGE BY OPTICAL COHERENCE TOMOGRAPHY AFTER PARS PLANA VITRECTOMY.
7/2016RECALCITRANT CYSTOID MACULAR EDEMA AFTER PARS PLANA VITRECTOMY.
7/2016REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.
4/2014Restoration of retinal layers after epiretinal membrane peeling.
4/2012Retinal adherence and fibrillary surface changes correlate with surgical difficulty of epiretinal membrane removal.
9/2010Vitreoretinal interface abnormalities in healed cytomegalovirus retinitis.
3/2010Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
2/2010Spectral domain optical coherence tomography for imaging ERM, retinal edema, and vitreomacular interface.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William R Freeman Research Topics

Disease

41Macular Degeneration (Age-Related Maculopathy)
10/2021 - 10/2002
24Macular Edema
01/2018 - 09/2003
21Choroidal Neovascularization
10/2019 - 10/2002
19Retinitis
01/2015 - 02/2002
17Epiretinal Membrane (Epiretinal Membranes)
07/2019 - 09/2003
10Diabetic Retinopathy (Retinopathy, Diabetic)
10/2019 - 06/2011
8Uveitis
06/2012 - 09/2003
7Retinal Perforations
07/2016 - 08/2002
6Inflammation (Inflammations)
10/2021 - 03/2006
6Cataract (Cataracts)
11/2020 - 02/2002
6Cytomegalovirus Retinitis
04/2011 - 09/2002
6Acquired Immunodeficiency Syndrome (AIDS)
02/2007 - 06/2002
5Retinal Diseases
10/2021 - 01/2002
5Retinal Detachment (Retinal Detachments)
12/2020 - 09/2002
5Cicatrix (Scar)
11/2018 - 09/2010
4Ganglion Cysts (Ganglion)
11/2021 - 12/2009
4Hemorrhage
03/2018 - 10/2004
4Infections
01/2015 - 02/2002
4Burns
06/2011 - 10/2004
4Neoplasms (Cancer)
07/2008 - 02/2002
3Geographic Atrophy
01/2021 - 09/2009
3Glaucoma
11/2018 - 09/2002
3Edema (Dropsy)
11/2018 - 10/2007
3Melanoma (Melanoma, Malignant)
04/2018 - 09/2002
3Toxic Optic Neuropathy
06/2013 - 01/2012
3Microaneurysm
05/2013 - 06/2011
3Cysts
06/2012 - 01/2008
3Gliosis
09/2010 - 04/2006
2Blindness (Hysterical Blindness)
11/2021 - 10/2016
2Pain (Aches)
06/2021 - 12/2005
2Disease Progression
06/2021 - 03/2004
2Proliferative Vitreoretinopathy
01/2018 - 01/2012
2Retinal Neovascularization
01/2018 - 01/2002
2Retinal Vein Occlusion
07/2016 - 02/2008
2Choroid Diseases
12/2015 - 12/2012
2Papilledema
01/2015 - 11/2007
2Vision Disorders (Hemeralopia)
01/2014 - 06/2012
2Hyperpigmentation
09/2006 - 10/2002
2Uveal melanoma
09/2002 - 02/2002
1Retinal Vasculitis
10/2021
1Late-Onset Retinal Degeneration
06/2021
1Atrophy
06/2021
1Cardiovascular Diseases (Cardiovascular Disease)
03/2021
1Infarction (Infarctions)
03/2021
1Ischemia
03/2021
1Vitreous Hemorrhage
08/2020

Drug/Important Bio-Agent (IBA)

49Retinaldehyde (Retinal)IBA
06/2021 - 02/2002
12Pharmaceutical PreparationsIBA
11/2020 - 02/2002
12Fluorescein (Funduscein)FDA LinkGeneric
11/2018 - 10/2002
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 08/2008
9Bevacizumab (Avastin)FDA Link
04/2017 - 07/2007
7afliberceptIBA
04/2019 - 03/2015
7Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2017 - 03/2006
5Triamcinolone (Aristocort)FDA Link
01/2017 - 02/2007
5SteroidsIBA
06/2012 - 06/2004
4Cidofovir (Vistide)FDA Link
01/2015 - 10/2003
4prinomastat (Ag3340)IBA
10/2004 - 01/2002
3Ranibizumab (Lucentis)FDA Link
08/2020 - 06/2012
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2017 - 12/2002
3LipidsIBA
01/2015 - 04/2011
3ProdrugsIBA
01/2012 - 04/2011
2Biomarkers (Surrogate Marker)IBA
10/2021 - 03/2021
2Lidocaine (Xylocaine)FDA LinkGeneric
06/2021 - 12/2005
2N-acetyltryptophanamide (NATA)IBA
01/2020 - 01/2016
2Endothelial Growth FactorsIBA
03/2018 - 09/2015
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 12/2014
2Coloring Agents (Dyes)IBA
11/2017 - 10/2009
2brincidofovirIBA
01/2015 - 12/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2014 - 08/2008
2Silicone OilsIBA
06/2010 - 11/2005
2Retinal Pigments (Pigments, Visual)IBA
09/2009 - 10/2002
2DNA (Deoxyribonucleic Acid)IBA
04/2006 - 02/2006
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2006 - 02/2004
2Antiviral Agents (Antivirals)IBA
11/2004 - 02/2002
2Matrix Metalloproteinases (MMPs)IBA
10/2004 - 02/2002
1iridium oxideIBA
11/2021
1brolucizumabIBA
10/2021
1proxymetacaine (Alcaine)FDA LinkGeneric
06/2021
1Hemoglobins (Hemoglobin)IBA
03/2021
1Triglycerides (Triacylglycerol)IBA
03/2021
1CholesterolIBA
03/2021
1salicylhydroxamic acid (SHAM)IBA
01/2021
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
01/2021
1Hyaluronic Acid (Hyaluronan)IBA
12/2020
1Silicon Dioxide (Silica)FDA LinkGeneric
11/2020
1Polymethyl Methacrylate (Sol)IBA
11/2020
1KetorolacIBA
11/2020
1Ophthalmic Solutions (Eye Drops)IBA
11/2020

Therapy/Procedure

31Lasers (Laser)
07/2019 - 09/2002
20Therapeutics
10/2021 - 02/2002
12Injections
04/2019 - 02/2002
10Vitrectomy
04/2021 - 08/2002
8Intravitreal Injections
12/2020 - 02/2002
7Traction
07/2016 - 08/2008
7Highly Active Antiretroviral Therapy (HAART)
04/2011 - 06/2002
5Light Coagulation
08/2014 - 10/2002
4Semiconductor Lasers
02/2011 - 10/2002
3Aftercare (After-Treatment)
06/2013 - 10/2002
2Visual Prosthesis
12/2018 - 10/2016
1Electrodes (Electrode)
11/2021